Sintx Technologies (SINT) EPS (Weighted Average and Diluted) Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.66% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.81% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.98% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 27.51% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.01% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 26.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.18% |
| Dec 31, 2025 | 53.57% |
| Sep 30, 2025 | 52.49% |
| Jun 30, 2025 | 55.68% |
| Mar 31, 2025 | 51.79% |
| Dec 31, 2024 | 28.28% |
| Sep 30, 2024 | -298.48% |
| Jun 30, 2024 | -242.31% |
| Mar 31, 2024 | -481.78% |
| Dec 31, 2023 | -654.49% |
| Sep 30, 2023 | -1,035.88% |
| Jun 30, 2023 | -660.80% |
| Mar 31, 2023 | -4.38% |
| Dec 31, 2022 | -875.28% |
| Sep 30, 2022 | -130.19% |
| Jun 30, 2022 | -37.84% |
| Mar 31, 2022 | -72.56% |
| Dec 31, 2021 | -13.36% |
| Sep 30, 2021 | 81.65% |
| Jun 30, 2021 | 80.46% |
| Mar 31, 2021 | 53.44% |